Other than an adjuvant developed by NIH to increase the efficacy of Covaxin I do not see why you claim Covaxin itself was developed by NIH. AFAIK it was develo

Other than an adjuvant developed by NIH to increase the efficacy of Covaxin I do not see why you claim Covaxin itself was developed by NIH. AFAIK it was developed by Indian agencies. Other than that, I agree with this comment. But it is not a new problem. It is a very old problem, since way way before the pandemic. There is no pandemic related evil here. FDA restricts the import of foreign cheaper drugs for various reasons including patents.